Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ashwini Manjunath"'
Autor:
Mithua Ghosh, Radheshyam Naik, Sheela Mysore Lingaraju, Sridhar Papaiah Susheela, Shekar Patil, Gopinath Kodaganur Srinivasachar, Satheesh Chiradoni Thungappa, Krithika Murugan, Srinivas Belagutty Jayappa, Somorat Bhattacharjee, Nalini Rao, Mahesh Bandimegal, Roopesh Krishnappa, Shashidhara Haragadde Poppareddy, Krishna Chennagiri Raghavendrachar, Yogesh Shivakumar, Sunitha Nagesh, Ramya Kodandapani, Ashwini Rajan, Urvashi Bahadur, Pooja Agrawal, Veena Ramaswamy, Tejaswini Bangalore Nanjaiah, Sateesh Kunigal, Shanmukh Katragadda, Ashwini Manjunath, Amritanshu Ram, Basavalinga S. Ajaikumar
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100877- (2021)
Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with th
Externí odkaz:
https://doaj.org/article/e9673ac8e9e6409397fe2c7fd81d504b
Publikováno v:
Archives of Microbiology. 205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2913531f3af030f964a797215519ad4b
https://doi.org/10.1007/s00203-023-03504-0
https://doi.org/10.1007/s00203-023-03504-0
Publikováno v:
The Journal of Antibiotics. 75:185-198
Antimicrobial resistance is one of the vital challenges facing global health today. Multi-drug resistant (MDR) infections are often treated with the narrow-spectrum drugs, colistin (polymyxin E) or polymyxin B, which are last-resort antibiotics for h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d4b82d0f18bce748085a079cf8657d
https://doi.org/10.1038/s41429-022-00502-0
https://doi.org/10.1038/s41429-022-00502-0
Publikováno v:
Microbial Enzymes in Production of Functional Foods and Nutraceuticals ISBN: 9781003311164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::103a141d0dd9d9da50d70f9fdbd93c77
https://doi.org/10.1201/9781003311164-4
https://doi.org/10.1201/9781003311164-4
Publikováno v:
Lecture Notes in Civil Engineering ISBN: 9789811940392
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd1f6b5d9eb9ba18f45c52e817b03981
https://doi.org/10.1007/978-981-19-4040-8_40
https://doi.org/10.1007/978-981-19-4040-8_40
Publikováno v:
Biologia. 76:3029-3041
Heteroresistance is a phenomenon where a subset of bacterial cells shows higher resistance towards antibiotic while the majority are susceptible to the same. Till date, a few reports have been emerged with prevalence of heteroresistance in several ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8adae524f111c3103c7909a89a4424f5
https://doi.org/10.1007/s11756-021-00820-y
https://doi.org/10.1007/s11756-021-00820-y
Autor:
Pallavi Ghana, Kathy T. H. Tzeng, Aparna Ganapathy, Ramesh Hariharan, Radhakrishna Bettadapura, Ashwini Manjunath, Joline Dalton, Vamsi Veeramachaneni, Anand Janakiraman, Shradha Saraf, Ashraf U Mannan, Shanmukh Katragadda, Niveditha Ms, Kumar B V S S P Kotha, Taryn O. Hall
Publikováno v:
Clinical chemistry. 67(8)
Background Multi–gene panel sequencing using next-generation sequencing (NGS) methods is a key tool for genomic medicine. However, with an estimated 140 000 genomic tests available, current system inefficiencies result in high genetic-testing costs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053291573bda7ce2555e61d0a2eef498
https://pubmed.ncbi.nlm.nih.gov/34120169
https://pubmed.ncbi.nlm.nih.gov/34120169
Autor:
Nishant Agrawal, Jayalakshmi Nair, Shanmukh Katragadda, Ramesh Hariharan, Radhakrishna Bettadapura, Vaijayanti Gupta, Vamsi Veeramachaneni, Ritvi K. Bagadia, Sivaraj Irusappan, Shiuli Maji, Mark W. Lingen, Vishal Rao, Muddasir Bhati, Urvashi Bahadur, Veena Ramaswamy, Nickolas Papadopoulos, Arun K Hariharan, Rifat Hasina, Chetan Bettegowda, Aarthi Ravichandran, Ashwini Shanmugam, Evgeny Izumchenko, Monica Charlotte Solomon, Netravathi Manjunath, Ashwini Manjunath
Publikováno v:
Cancer
BACKGROUND: Oral cavity squamous cell carcinoma (OCSCC) is the most common head and neck malignancy. Although the survival rate of patients with advanced-stage disease remains approximately 20% to 60%, when detected at an early stage, the survival ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d44cdae2564f7b50e9c62e716c6dbd7
https://pubmed.ncbi.nlm.nih.gov/33405231
https://pubmed.ncbi.nlm.nih.gov/33405231
Autor:
Amritanshu Ram, Ashwini R, Mithua Ghosh, Nimmy Ramdas, Satheesh C.T, Sateesh S. Kunigal, K. Murugan, Urvashi Bahadur, Raghavendra M Rao, B. Mahesh, Ajai Kumar, Sheela Ml, Pooja Agrawal, Radheshyam Naik, K. C. Ramya, Tejaswini Bn, Sunitha N, Pooja Sridhar, Nalini Rao, R. Veena, Shekar Patil, Srinivas B.J, Shanmukh Katragadda, Krishna Cr, Shashidhara H P, Yogesh S, Ashwini Manjunath
Publikováno v:
International e-Conference on Cancer Research 2019.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90fa6a91a32a350fe42990410444be04
https://doi.org/10.28991/iccr-2019-013
https://doi.org/10.28991/iccr-2019-013
Autor:
Satheesh Chiradoni Thungappa, Krishna Chennagiri Raghavendrachar, Gopinath Kodaganur Srinivasachar, Nalini Rao, Sridhar Papaiah Susheela, Sheela Mysore Lingaraju, Shekar Patil, Mithua Ghosh, Srinivas Belagutty Jayappa, Sunitha Nagesh, Urvashi Bahadur, Veena Ramaswamy, Somorat Bhattacharjee, Ashwini Manjunath, Shanmukh Katragadda, Sateesh S. Kunigal, Roopesh Krishnappa, Mahesh Bandimegal, Basavalinga S. Ajaikumar, Amritanshu Ram, Shashidhara Haragadde Poppareddy, Radheshyam Naik, K. Murugan, Yogesh Shivakumar, Ashwini Rajan, Tejaswini Bangalore Nanjaiah, Pooja Agrawal, Ramya Kodandapani
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 1, Pp 100877-(2021)
Translational Oncology, Vol 14, Iss 1, Pp 100877-(2021)
Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f2c6a614ab63155589645de7718ae9
https://doi.org/10.1016/j.tranon.2020.100877
https://doi.org/10.1016/j.tranon.2020.100877